Specifications tableSubjectBacterial SequencingSpecific subject areaGenomicsType of dataGenome sequences (DNA-Seq raw reads)How data were acquiredIllumina MiSeq sequencing platform (Illumina, San Diego, CA, USA)Data formatRaw sequences (FASTQ)Parameters for data collectionGenomic DNA was extracted from purified cultures of *Escherichia coli* and quantified, following which libraries were prepared and quality checked for sequencing.Description of data collectionDNA extraction was performed using the Geneaid Presto™ Mini gDNA Bacteria Kit (with lysozyme) (Geneaid, New Taipei City, Taiwan). DNA isolate purity was quantified with a Qubit® 3.0 Fluorometer (Thermo Fisher Scientific, Waltham, MA, USA) using a target-specific Qubit assay (dsDNA BR Assay Kit, Thermo Fisher Scientific). Libraries were prepared using the Nextera™ DNA Flex Library Prep Kit (Illumina®) and library quality was examined using The Agilent 4200 TapeStation system (G2991AA) (Agilent, Santa Clara, CA, USA). Sequencing was performed using the Illumina MiSeq system.Data source locationFaculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaData accessibilityRaw data (FASTQ) files of *Escherichia coli* have been deposited in the National Center for Biotechnology Information, <https://www.ncbi.nlm.nih.gov/>, under BioProject database: <https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA596854>, BioSample database: (<https://www.ncbi.nlm.nih.gov/biosample?LinkName=bioproject_biosample_all&from_uid=596854>), and Sequence Read Archive (SRA) database: <https://www.ncbi.nlm.nih.gov/sra?linkname=bioproject_sra_all&from_uid=596854> with accession number: SRR10761126--SRR10761147.

Value of the data {#sec0001a}
=================

•These data shed light on the molecular biology of *E. coli* found in bloodstream infections.•These data provide insights into antibiotic resistance in *E. coli,* which will be beneficial to clinicians and patients.•The data will help us understand the genomic mechanisms underlying the severity of *E. coli*-caused bloodstream infections.

1. Data Description {#sec0001}
===================

*E. coli* (Gram-negative bacterial commensals) naturally exists in the human gastrointestinal tract. Pathogenicity, virulence, and multidrug resistance features of pathogenic *E. coli* are routinely obtained by commensal *E. coli* through horizontal transfer and other mechanisms. Virulent *E. coli* share pathogenic factors, virulence, and resistance with less virulent strains, causing overlapping pathogenesis beyond their natural capability [@bib0001].

We present whole genome sequence data of 22 *E. coli* isolates obtained from bloodstream infection patients admitted to Cipto Mangunkusumo National Hospital, Jakarta, Indonesia. Purified *E. coli* DNA was quantified using Qubit 3.0 ([Table 1](#tbl0001){ref-type="table"}). The quality of library preparations was checked using the Agilent 4200 TapeStation system and found to be equal to that of the reference ([Fig. 1](#fig0001){ref-type="fig"} and [Table 2](#tbl0002){ref-type="table"}). Electrophoresis strengthened these results ([Fig. 2](#fig0002){ref-type="fig"}). Sequencing was performed using the Illumina MiSeq system.Table 1DNA library purification and concentrations using Qubit 3.0.Table 1SamplePurity 260/280Qubit 3.0 (C) (μg/ml)RSCM_EC_0102225.9RSCM_EC_02032.02842.5RSCM_EC_03051.80819.7RSCM_EC_04061.93928.1RSCM_EC_05071.91440.7RSCM_EC_06081.930.2RSCM_EC_07092.03830.5RSCM_EC_0911219.6RSCM_EC_10132.04333RSCM_EC_11142.0549.3RSCM_EC_13161.94357RSCM_EC_14181.95521.7RSCM_EC_15262.05929.7RSCM_EC_16281.9516.3RSCM_EC_17322.05351RSCM_EC_1833242.6RSCM_EC_19351.94439.9RSCM_EC_20361.86449.3RSCM_EC_2137230RSCM_EC_2240236.9RSCM_EC_2341236RSCM_EC_2442243.2Fig. 1Library size profiles using the Agilent 4200 TapeStation system. A) Reference Guide [@bib0002] and B) Experimental *E. coli* libraries.Fig 1Table 2*E. coli* library regions quality-checked using the Agilent 4200 TapeStation system.Table 2SampleFrom (bp)To (bp)Average Size (bp)Conc. (μg/μl)Region Molarity (nmol/l)% of TotalRSCM_EC_0203 (A1)31410165933.158.6967.5RSCM_EC_0305 (B1)2549104894.9516.579.2RSCM_EC_0911 (C1)2538774594.5716.279.7RSCM_EC_1114 (D1)2809285095.5317.784.9RSCM_EC_1316 (E1)2489195044.4114.382.4Fig. 2Electrophoresis of five *E. coli* DNA library samples. EL1: Genomic DNA ladder (as reference); A1: RSCM_EC_0203; B1: RSCM_EC_0305; C1: RSCM_EC_0911; D1: RSCM_EC_1114; E1: RSCM_EC_1316).Fig 2

Paired-end libraries were obtained from sequencing runs ([Table 3](#tbl0003){ref-type="table"}). FASTQ raw data files have been deposited in the NCBI database under BioProject accession number PRJNA596854 (<https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA596854>), BioSample database: (<https://www.ncbi.nlm.nih.gov/biosample?LinkName=bioproject_biosample_all&from_uid=596854>) and Sequence Read Archive (SRA) accession numbers: SRR10761126--SRR10761147 (<https://www.ncbi.nlm.nih.gov/sra?linkname=bioproject_sra_all&from_uid=596854>). These data will be useful for analysing the serotypes, virulence genes, and antimicrobial resistance genes of *E. coli.*Table 3Descriptive information for whole genome sequencing of raw *E. coli* data.Table 3SampleTotal Raw Reads (Mb)Total bases (Mbp)GC Content (%)BioSample Accession NumberSRA Accession NumberRSCM_EC_01020.56311.850.4SAMN13640292SRS5880528RSCM_EC_02030.97503.150.2SAMN13640311SRS5880529RSCM_EC_03051.7883.550.2SAMN13640332SRS5880540RSCM_EC_04061.6875.350.3SAMN13640527SRS5880543RSCM_EC_05072.2120050.3SAMN13640528SRS5880544RSCM_EC_06081.3655.249.6SAMN13640529SRS5880545RSCM_EC_07091.6879.550.8SAMN13640533SRS5880546RSCM_EC_09111.683550.5SAMN13640535SRS5880547RSCM_EC_10130.9465.650.5SAMN13640581SRS5880548RSCM_EC_11141.8971.450.2SAMN13640826SRS5880549RSCM_EC_13161.1592.950.3SAMN13640832SRS5880530RSCM_EC_14180.90512.750.0SAMN13640834SRS5880531RSCM_EC_15261.3661.550.8SAMN13640837SRS5880532RSCM_EC_16280.93492.049.9SAMN13640838SRS5880533RSCM_EC_17322.7150050.0SAMN13640846SRS5880534RSCM_EC_18331.0562.050.0SAMN13640847SRS5880535RSCM_EC_19350.92466.650.7SAMN13640849SRS5880536RSCM_EC_20361.27665.550.4SAMN13640850SRS5880537RSCM_EC_21370.46254.250.4SAMN13640852SRS5880538RSCM_EC_22400.84476.650.4SAMN13640877SRS5880539RSCM_EC_23411.4749.650.6SAMN13640878SRS5880541RSCM_EC_24422.3110049.9SAMN13640880SRS5880542

2. Experimental Design, Materials, and Methods {#sec0002}
==============================================

2.1. Sample collection and bacteria culturing {#sec0003}
---------------------------------------------

*E. coli* were isolated from blood samples of bloodstream infection patients, who varied in gender and age and were admitted to Cipto Mangunkusumo National Hospital in 2018. After isolation, the *E. coli* were cultured in Lactose Broth medium in the laboratory facilities at the Centre for Research and Development of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Indonesia.

2.2. DNA isolation and quantification {#sec0004}
-------------------------------------

DNA extraction was performed using a Geneaid Presto™ Mini gDNA Bacteria Kit (with lysozyme). DNA sample purity was determined from the 260/280 nm absorbance values with a ratio of 1.8--2.0 indicating a pure DNA sample [@bib0002]. Pure DNA isolates were then quantified using a Qubit® 3.0 Fluorometer (Thermo Fisher Scientific) and a target-specific Qubit assay (dsDNA BR Assay Kit, Thermo Fisher Scientific). Initially, 43 DNA samples were prepared; however, 22 samples were chosen for DNA sequencing based on their high purity and adequate concentration ([Table 1](#tbl0001){ref-type="table"}).

2.3. Library preparation and quality checking {#sec0005}
---------------------------------------------

DNA libraries were prepared using the Nextera™ DNA Flex Library Prep Kit (Illumina) according to the manufacturer\'s protocol. Five random libraries were quality checked using the Agilent 4200 TapeStation system (G2991AA). The *E. coli* library profile showed similarities with that of the Reference Guide of the Nextera™ DNA Flex Library Prep Kit [@bib0002]. [Fig. 1](#fig0001){ref-type="fig"} shows typical library size profiles with an average fragment size of 600 bp when analysed with a size range of 150--1500 bp. Specific region details are shown in [Table 2](#tbl0002){ref-type="table"}. The library quality was also strengthened by the electrophoresis results that showed each of the five libraries having a fragment size of approximately 300--1000 bp ([Fig. 2](#fig0002){ref-type="fig"}). Thus, it was demonstrated that the quality of the *E. coli* libraries met the Illumina MiSeq platform requirements.

2.4. Whole genome sequencing and data {#sec0006}
-------------------------------------

The *E. coli* libraries were sequenced using the Illumina MiSeq platform according to the following steps: 1) Denaturing the libraries; 2) Diluting the libraries; 3) Preparing the optional PhiX control; 4) Loading the libraries onto the reagent cartridge; and 5) Setting up the sequencing run [@bib0003]. Paired-end libraries were obtained from sequencing runs ([Table 3](#tbl0003){ref-type="table"}). The data sequences were deposited in the SRA under BioProject accession number PRJNA596854.
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